Tortoise Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-18
Closed -$2K 626
2019
Q4
$2K Hold
18
﹤0.01% 549
2019
Q3
$2K Hold
18
﹤0.01% 553
2019
Q2
$3K Hold
18
﹤0.01% 550
2019
Q1
$3K Hold
18
﹤0.01% 537
2018
Q4
$2K Hold
18
﹤0.01% 515
2018
Q3
$3K Hold
18
﹤0.01% 494
2018
Q2
$3K Buy
+18
New +$2.56K ﹤0.01% 509
2018
Q1
Sell
-18
Closed -$2K 578
2017
Q4
$2K Hold
18
﹤0.01% 530
2017
Q3
$2K Hold
18
﹤0.01% 463
2017
Q2
$2K Buy
+18
New +$1.94K ﹤0.01% 462

Other funds holding GWPH

Tortoise Investment Management's GWPH Position: Q1 2020 in Review

Tortoise Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 18 shares — an estimated $2K sold.

Tortoise Investment Management first reported a position in GWPH in Q2 2017 and held it in 10 quarters. The position peaked at $3K in Q2 2019. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

  • Tortoise Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
  • Tortoise Investment Management sold 18 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $2K.
  • Tortoise Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2017 and held it in 10 quarters.
  • Tortoise Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3K in Q2 2019.
  • 289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Tortoise Investment Management's 13F filing for Q1 2020, filed 5 May 2020.